Burgess MA - Search Results

1

The cost-effectiveness of varicella vaccine programs for Australia.

Scuffham PA, Lowin AV, Burgess MA. Scuffham PA, et al. Among authors: burgess ma. Vaccine. 1999 Oct 14;18(5-6):407-15. doi: 10.1016/s0264-410x(99)00261-3. Vaccine. 1999. PMID: 10519929

2

Varicella vaccination of health-care workers.

Burgess MA, Cossart YE, Wilkins TD, Botham S, Fearns G, Chitour K. Burgess MA, et al. Vaccine. 1999 Feb 26;17(7-8):765-9. doi: 10.1016/s0264-410x(98)00260-6. Vaccine. 1999. PMID: 10067681 Clinical Trial.

3

Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia.

Gao Z, Wood JG, Burgess MA, Menzies RI, McIntyre PB, MacIntyre CR. Gao Z, et al. Among authors: burgess ma. Vaccine. 2013 Jan 11;31(4):691-7. doi: 10.1016/j.vaccine.2012.11.043. Epub 2012 Nov 26. Vaccine. 2013. PMID: 23196206

4

Varicella vaccination in Australia.

Macartney KK, Beutels P, McIntyre P, Burgess MA. Macartney KK, et al. Among authors: burgess ma. J Paediatr Child Health. 2005 Nov;41(11):544-52. doi: 10.1111/j.1440-1754.2005.00717.x. J Paediatr Child Health. 2005. PMID: 16398834 Review.

5

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

McIntyre PB, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM. McIntyre PB, et al. Among authors: burgess ma. Vaccine. 2004 Dec 2;23(3):380-5. doi: 10.1016/j.vaccine.2004.05.030. Vaccine. 2004. PMID: 15530684 Clinical Trial.

6

Varicella vaccination in Australia and New Zealand.

Macartney KK, Burgess MA. Macartney KK, et al. Among authors: burgess ma. J Infect Dis. 2008 Mar 1;197 Suppl 2:S191-5. doi: 10.1086/522157. J Infect Dis. 2008. PMID: 18419396

7

Antibody persistence six years after two doses of combined hepatitis A and B vaccine.

Burgess MA, McIntyre PB, Hellard M, Ruff TA, Lefevre I, Bock HL. Burgess MA, et al. Vaccine. 2010 Mar 2;28(10):2222-2226. doi: 10.1016/j.vaccine.2009.12.053. Epub 2010 Jan 5. Vaccine. 2010. PMID: 20056187

8

Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.

Burgess MA, Rodger AJ, Waite SA, Collard F. Burgess MA, et al. Vaccine. 2001 Sep 14;19(32):4835-41. doi: 10.1016/s0264-410x(01)00221-3. Vaccine. 2001. PMID: 11535336 Clinical Trial.

9

Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia.

Gidding HF, Brisson M, Macintyre CR, Burgess MA. Gidding HF, et al. Among authors: burgess ma. Aust N Z J Public Health. 2005 Dec;29(6):544-51. doi: 10.1111/j.1467-842x.2005.tb00248.x. Aust N Z J Public Health. 2005. PMID: 16366065 Free article.

10

The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?

Burgess DC, Burgess MA, Leask J. Burgess DC, et al. Among authors: burgess ma. Vaccine. 2006 May 1;24(18):3921-8. doi: 10.1016/j.vaccine.2006.02.033. Epub 2006 Mar 3. Vaccine. 2006. PMID: 16564116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page